Levi & Korsinsky, LLP notifies investors in Indivior PLC ("Indivior" or the "Company") of a class action securities lawsuit.
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Indivior (INDV – Research Report), with a ...
In a sample of people who regularly use ecstasy and other illicit stimulants, 54% reported using pharmaceutical stimulants ...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, both dates inclusive (the "Class Period") ...
On Friday, Piper Sandler affirmed its positive stance on Indivior (NASDAQ: INDV), maintaining an Overweight rating and a $22.00 price target for the pharmaceutical company's stock. The firm's ...
NEW YORK, Sept. 17, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of securities of Indivior PLC (NASDAQ: INDV) between February 22 ...
Piper Sandler has recently initiated Indivior PLC (INDV) stock to Overweight rating, as announced on July 23, 2024, according to Finviz. Earlier, on April 3, 2024, Craig Hallum had initiated the stock ...
LOS ANGELES, Sept. 17, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ: INDV) for violations of §§10(b) ...
THE LAWSUIT: A class action securities lawsuit was filed against Indivior PLC that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 22, ...
On Friday, Piper Sandler affirmed its positive stance on Indivior (NASDAQ: INDV), maintaining an Overweight rating and a $22.00 price target for the pharmaceutical company's stock. The firm's analysis ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") for violations of 10(b) and 20(a) of ...